Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 195

1.

Latency and interval therapy affect the evolution in metastatic colorectal cancer.

Nikbakht H, Jessa S, Sukhai MA, Arseneault M, Zhang T, Letourneau L, Thomas M, Bourgey M, Roehrl MHA, Eveleigh R, Chen EX, Krzyzanowska M, Moore MJ, Giesler A, Yu C, Bedard PL, Kamel-Reid S, Majewski J, Siu LL, Riazalhosseini Y, Graham DM.

Sci Rep. 2020 Jan 17;10(1):581. doi: 10.1038/s41598-020-57476-y.

2.

A primer on the genetics of medullary thyroid cancer.

Larouche V, Akirov A, Thomas CM, Krzyzanowska MK, Ezzat S.

Curr Oncol. 2019 Dec;26(6):389-394. doi: 10.3747/co.26.5553. Epub 2019 Dec 1. Review.

3.

Readiness for delivering early palliative care: A survey of primary care and specialised physicians.

Sorensen A, Le LW, Swami N, Hannon B, Krzyzanowska MK, Wentlandt K, Rodin G, Zimmermann C.

Palliat Med. 2020 Jan;34(1):114-125. doi: 10.1177/0269216319876915. Epub 2019 Dec 18.

PMID:
31849272
4.

Cross-Canada differences in early-stage breast cancer treatment and acute-care use.

Powis M, Groome P, Biswanger N, Kendell C, Decker KM, Grunfeld E, McBride ML, Urquhart R, Winget M, Porter GA, Krzyzanowska MK.

Curr Oncol. 2019 Oct;26(5):e624-e639. doi: 10.3747/co.26.5003. Epub 2019 Oct 1.

5.

Development and Validation of a Score to Predict Acute Care Use After Initiation of Systemic Therapy for Cancer.

Grant RC, Moineddin R, Yao Z, Powis M, Kukreti V, Krzyzanowska MK.

JAMA Netw Open. 2019 Oct 2;2(10):e1912823. doi: 10.1001/jamanetworkopen.2019.12823.

6.

Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocol.

Krzyzanowska MK, Julian JA, Powis M, Howell D, Earle CC, Enright KA, Mittmann N, Trudeau ME, Grunfeld E.

BMC Cancer. 2019 Sep 5;19(1):884. doi: 10.1186/s12885-019-6099-x.

7.

Estimating the optimal perioperative chemotherapy utilization rate for muscle-invasive bladder cancer.

Karim S, Mackillop WJ, Brennan K, Peng Y, Siemens DR, Krzyzanowska MK, Booth CM.

Cancer Med. 2019 Oct;8(14):6258-6271. doi: 10.1002/cam4.2449. Epub 2019 Aug 31.

8.

Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer.

Karim S, Booth CM, Brennan K, Peng Y, Siemens DR, Krzyzanowska MK, Mackillop WJ.

Cancer Med. 2019 Sep;8(12):5590-5599. doi: 10.1002/cam4.2456. Epub 2019 Aug 12.

9.

Cell-Based Therapies for Chronic Wounds Tested in Clinical Studies: Review.

Domaszewska-Szostek A, Krzyżanowska M, Siemionow M.

Ann Plast Surg. 2019 Dec;83(6):e96-e109. doi: 10.1097/SAP.0000000000001947.

PMID:
31335465
10.

Medical oncologists' and palliative care physicians' opinions towards thromboprophylaxis for inpatients with advanced cancer: a cross-sectional study.

Hannon B, Taback N, Zimmermann C, Granton J, Krzyzanowska M.

BMJ Support Palliat Care. 2019 Jul 11. pii: bmjspcare-2019-001861. doi: 10.1136/bmjspcare-2019-001861. [Epub ahead of print]

PMID:
31296519
11.

Practices and opinions of specialized palliative care physicians regarding early palliative care in oncology.

Sorensen A, Wentlandt K, Le LW, Swami N, Hannon B, Rodin G, Krzyzanowska MK, Zimmermann C.

Support Care Cancer. 2020 Feb;28(2):877-885. doi: 10.1007/s00520-019-04876-0. Epub 2019 Jun 4.

PMID:
31165335
12.

Drug interactions and oncological outcomes: a hidden adversary.

Riechelmann RP, Krzyzanowska MK.

Ecancermedicalscience. 2019 Mar 28;13:ed88. doi: 10.3332/ecancer.2019.ed88. eCollection 2019.

13.

A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial.

O'Kane GM, Ezzat S, Joshua AM, Bourdeau I, Leibowitz-Amit R, Olney HJ, Krzyzanowska M, Reuther D, Chin S, Wang L, Brooks K, Hansen AR, Asa SL, Knox JJ.

Br J Cancer. 2019 Jun;120(12):1113-1119. doi: 10.1038/s41416-019-0474-x. Epub 2019 May 20.

PMID:
31105270
14.

Clinical and Cost-effectiveness of a Comprehensive geriatric assessment and management for Canadian elders with Cancer-the 5C study: a study protocol for a randomised controlled phase III trial.

Puts MTE, Hsu T, Mariano C, Monette J, Brennenstuhl S, Pitters E, Ray J, Wan-Chow-Wah D, Kozlowski N, Krzyzanowska M, Amir E, Elser C, Jang R, Prica A, Krahn M, Beland F, Bergman S, Koneru R, Lemonde M, Szumacher E, Zidulka J, Fung S, Li A, Emmenegger U, Mehta R, Flemming K, Breunis H, Alibhai SMH.

BMJ Open. 2019 May 10;9(5):e024485. doi: 10.1136/bmjopen-2018-024485.

15.

The association of continuity of care and cancer centre affiliation with outcomes among patients with cancer who require emergency department care.

Grewal K, Sutradhar R, Krzyzanowska MK, Redelmeier DA, Atzema CL.

CMAJ. 2019 Apr 23;191(16):E436-E445. doi: 10.1503/cmaj.180962.

16.

User-Centered Design of a Web-Based Tool to Support Management of Chemotherapy-Related Toxicities in Cancer Patients.

Prince RM, Soung Yee A, Parente L, Enright KA, Grunfeld E, Powis M, Husain A, Gandhi S, Krzyzanowska MK.

J Med Internet Res. 2019 Mar 28;21(3):e9958. doi: 10.2196/jmir.9958.

17.

Ambulatory Toxicity Management (AToM) Pilot: results of a pilot study of a pro-active, telephone-based intervention to improve toxicity management during chemotherapy for breast cancer.

Krzyzanowska MK, MacKay C, Han H, Eberg M, Gandhi S, Laferriere NB, Powis M, Howell D, Atzema CL, Chan KKW, Kukreti V, Mitchell S, Nayer M, Pasetka M, Knittel-Keren D, Redwood E.

Pilot Feasibility Stud. 2019 Mar 8;5:39. doi: 10.1186/s40814-019-0404-y. eCollection 2019.

18.

Ribosomal DNA transcription in prefrontal pyramidal neurons is decreased in suicide.

Krzyżanowska M, Steiner J, Pieśniak D, Karnecki K, Kaliszan M, Wiergowski M, Rębała K, Brisch R, Braun K, Jankowski Z, Kosmowska M, Chociej J, Gos T.

Eur Arch Psychiatry Clin Neurosci. 2019 Mar 11. doi: 10.1007/s00406-019-00996-0. [Epub ahead of print]

PMID:
30859295
19.

Thromboprophylaxis for inpatients with advanced cancer in palliative care settings: A systematic review and narrative synthesis.

Cai R, Zimmermann C, Krzyzanowska M, Granton J, Hannon B.

Palliat Med. 2019 May;33(5):486-499. doi: 10.1177/0269216319830860. Epub 2019 Mar 1.

PMID:
30819046
20.

Postmortem Analysis of Electrogram Records from an Implantable Cardioverter-Defibrillator (ICD) in the Reconstruction of a Road Traffic Accident.

Kaliszan M, Daniłowicz-Szymanowicz L, Kempa M, Tomczak E, Krzyżanowska M, Jankowski Z, Raczak G.

J Forensic Sci. 2019 Sep;64(5):1551-1554. doi: 10.1111/1556-4029.14037. Epub 2019 Feb 21.

PMID:
30791122
21.

Usability Evaluation of a Mobile Phone-Based System for Remote Monitoring and Management of Chemotherapy-Related Side Effects in Cancer Patients: Mixed-Methods Study.

Moradian S, Krzyzanowska MK, Maguire R, Morita PP, Kukreti V, Avery J, Liu G, Cafazzo J, Howell D.

JMIR Cancer. 2018 Dec 21;4(2):e10932. doi: 10.2196/10932.

22.

Real-World Approaches to Quality Improvement in Oncology.

Kamal AH, Krzyzanowska MK.

J Oncol Pract. 2018 Dec;14(12):757-759. doi: 10.1200/JOP.18.00657. No abstract available.

PMID:
30537457
23.

Hospitalisations and emergency department visits in cancer patients receiving systemic therapy: Systematic review and meta-analysis.

Prince RM, Powis M, Zer A, Atenafu EG, Krzyzanowska MK.

Eur J Cancer Care (Engl). 2019 Jan;28(1):e12909. doi: 10.1111/ecc.12909. Epub 2018 Sep 20.

PMID:
30238542
24.

Symptom burden in adults with thyroid cancer.

Sawka AM, Watt S, Rodin G, Ezzat S, Howell D, Tsang RW, Brierley JD, Krzyzanowska MK, Goldstein D, Li M.

Psychooncology. 2018 Oct;27(10):2517-2519. doi: 10.1002/pon.4853. Epub 2018 Aug 31. No abstract available.

PMID:
30102832
25.

Emergency department visits and unplanned hospitalizations in the treatment period for head and neck cancer patients treated with curative intent: A population-based analysis.

Eskander A, Krzyzanowska MK, Fischer HD, Liu N, Austin PC, Irish JC, Enepekides DJ, Lee J, Gutierrez E, Lockhart E, Raphael M, Singh S.

Oral Oncol. 2018 Aug;83:107-114. doi: 10.1016/j.oraloncology.2018.06.011. Epub 2018 Jun 19.

PMID:
30098764
26.

Additional germline findings from a tumor profiling program.

Stjepanovic N, Stockley TL, Bedard PL, McCuaig JM, Aronson M, Holter S, Semotiuk K, Leighl NB, Jang R, Krzyzanowska MK, Oza AM, Gupta A, Elser C, Ahmed L, Wang L, Kamel-Reid S, Siu LL, Kim RH.

BMC Med Genomics. 2018 Aug 9;11(1):65. doi: 10.1186/s12920-018-0383-5.

27.

Health status, emergency department visits, and oncologists' feedback: An analysis of secondary endpoints from a randomized phase II geriatric assessment trial.

Sattar S, Alibhai SMH, Brennenstuhl S, Kulik M, MacDonald ME, McWatters K, Lee K, Jang R, Amir E, Krzyzanowska MK, Joshua AM, Monette J, Wan-Chow-Wah D, Puts MTE.

J Geriatr Oncol. 2019 Jan;10(1):169-174. doi: 10.1016/j.jgo.2018.06.014. Epub 2018 Jul 21.

PMID:
30041978
28.

Preventable Diabetic Complications After a Cancer Diagnosis in Patients With Diabetes: A Population-Based Cohort Study.

Worndl E, Fung K, Fischer HD, Austin PC, Krzyzanowska MK, Lipscombe LL.

JNCI Cancer Spectr. 2018 Jan;2(1):pky008. doi: 10.1093/jncics/pky008. Epub 2018 May 11.

29.

Experiences and Expectations of Bereavement Contact among Caregivers of Patients with Advanced Cancer.

Makarem M, Mohammed S, Swami N, Pope A, Kevork N, Krzyzanowska M, Rodin G, Hannon B, Zimmermann C.

J Palliat Med. 2018 Aug;21(8):1137-1144. doi: 10.1089/jpm.2017.0530. Epub 2018 May 16.

PMID:
29768117
30.

The ongoing challenge of large anal cancers: prospective long term outcomes of intensity-modulated radiation therapy with concurrent chemotherapy.

Hosni A, Han K, Le LW, Ringash J, Brierley J, Wong R, Dinniwell R, Brade A, Dawson LA, Cummings BJ, Krzyzanowska MK, Chen EX, Hedley D, Knox J, Easson AM, Lindsay P, Craig T, Kim J.

Oncotarget. 2018 Apr 17;9(29):20439-20450. doi: 10.18632/oncotarget.24926. eCollection 2018 Apr 17.

31.

Factors associated with imaging in patients with early breast cancer after initial treatment.

Enright K, Desai T, Sutradhar R, Gonzalez A, Powis M, Taback N, Booth CM, Trudeau ME, Krzyzanowska MK.

Curr Oncol. 2018 Apr;25(2):126-132. doi: 10.3747/co.25.3838. Epub 2018 Apr 30.

32.

Geriatric oncology screening tools for CGA-based interventions: results from a phase II study of geriatric assessment and management for older adults with cancer.

Yokom DW, Alibhai SMH, Sattar S, Krzyzanowska MK, Puts MTE.

J Geriatr Oncol. 2018 Nov;9(6):683-686. doi: 10.1016/j.jgo.2018.03.001. Epub 2018 Mar 12.

PMID:
29540293
33.

DO BIOMARKERS VARY BY SOCIAL CLASS, EDUCATION AND REGION AND IS MIGRATION IMPORTANT? EVIDENCE FROM A COHORT OF BRITISH ADULTS.

Krzyżanowska M, Mascie-Taylor CGN.

J Biosoc Sci. 2019 Jan;51(1):95-117. doi: 10.1017/S0021932017000700. Epub 2018 Feb 1.

PMID:
29386080
34.

The Impact of Diabetes on Breast Cancer Treatments and Outcomes: A Population-Based Study.

Lega IC, Austin PC, Fischer HD, Fung K, Krzyzanowska MK, Amir E, Lipscombe LL.

Diabetes Care. 2018 Apr;41(4):755-761. doi: 10.2337/dc17-2012. Epub 2018 Jan 19.

PMID:
29351960
35.

Can Chemotherapy-Related Acute Care Visits Be Accurately Identified in Administrative Data?

Krzyzanowska MK, Enright K, Moineddin R, Yun L, Powis M, Ghannam M, Grunfeld E.

J Oncol Pract. 2018 Jan;14(1):e51-e58. doi: 10.1200/JOP.2017.023697. Epub 2017 Nov 20.

PMID:
29155611
36.

Molecular Profiling of Patients With Advanced Colorectal Cancer: Princess Margaret Cancer Centre Experience.

Chiu JW, Krzyzanowska MK, Serra S, Knox JJ, Dhani NC, Mackay H, Hedley D, Moore M, Liu G, Burkes RL, Brezden-Masley C, Roehrl MH, Craddock KJ, Tsao MS, Zhang T, Yu C, Kamel-Reid S, Siu LL, Bedard PL, Chen EX.

Clin Colorectal Cancer. 2018 Mar;17(1):73-79. doi: 10.1016/j.clcc.2017.10.010. Epub 2017 Oct 23.

PMID:
29128266
37.

Experiences of Canadian oncologists with difficult patient deaths and coping strategies used.

Granek L, Barbera L, Nakash O, Cohen M, Krzyzanowska MK.

Curr Oncol. 2017 Aug;24(4):e277-e284. doi: 10.3747/co.24.3527. Epub 2017 Aug 31.

38.

Chemotherapy and radiation treatment decision-making experiences of older adults with cancer: A qualitative study.

Sattar S, Alibhai SMH, Fitch M, Krzyzanowska M, Leighl N, Puts MTE.

J Geriatr Oncol. 2018 Jan;9(1):47-52. doi: 10.1016/j.jgo.2017.07.013. Epub 2017 Aug 19.

PMID:
28830737
39.

A randomized phase II trial of geriatric assessment and management for older cancer patients.

Puts MTE, Sattar S, Kulik M, MacDonald ME, McWatters K, Lee K, Brennenstuhl S, Jang R, Amir E, Krzyzanowska MK, Joshua AM, Monette J, Wan-Chow-Wah D, Alibhai SMH.

Support Care Cancer. 2018 Jan;26(1):109-117. doi: 10.1007/s00520-017-3820-7. Epub 2017 Jul 25.

PMID:
28741175
40.

2017 ASCO Quality Care Symposium: Nurturing a New and Growing Community of Practitioners.

Neuss M, Jacobson J, Krzyzanowska M.

J Oncol Pract. 2017 Aug;13(8):507-508. doi: 10.1200/JOP.2017.025833. Epub 2017 Jul 24. No abstract available.

PMID:
28737963
41.

Expanding the Spectrum of Colonic Manifestations in Tuberous Sclerosis: L-Cell Neuroendocrine Tumor Arising in the Background of Rectal PEComa.

Kolin DL, Duan K, Ngan B, Gerstle JT, Krzyzanowska MK, Somers GR, Mete O.

Endocr Pathol. 2018 Mar;29(1):21-26. doi: 10.1007/s12022-017-9497-0.

PMID:
28733877
42.

My Team of Care Study: A Pilot Randomized Controlled Trial of a Web-Based Communication Tool for Collaborative Care in Patients With Advanced Cancer.

Voruganti T, Grunfeld E, Jamieson T, Kurahashi AM, Lokuge B, Krzyzanowska MK, Mamdani M, Moineddin R, Husain A.

J Med Internet Res. 2017 Jul 18;19(7):e219. doi: 10.2196/jmir.7421.

43.

Pancreatic Neuroendocrine Tumor Producing Insulin and Vasopressin.

Alshaikh OM, Yoon JY, Chan BA, Krzyzanowska MK, Butany J, Asa SL, Ezzat S.

Endocr Pathol. 2018 Mar;29(1):15-20. doi: 10.1007/s12022-017-9492-5.

PMID:
28718084
44.

Setting Quality Improvement Priorities for Women Receiving Systemic Therapy for Early-Stage Breast Cancer by Using Population-Level Administrative Data.

Enright KA, Taback N, Powis ML, Gonzalez A, Yun L, Sutradhar R, Trudeau ME, Booth CM, Krzyzanowska MK.

J Clin Oncol. 2017 Oct 1;35(28):3207-3214. doi: 10.1200/JCO.2016.70.7950. Epub 2017 Jul 6.

PMID:
28682683
45.

Establishing achievable benchmarks for quality improvement in systemic therapy for early-stage breast cancer.

Powis M, Sutradhar R, Gonzalez A, Enright KA, Taback NA, Booth CM, Trudeau M, Krzyzanowska MK.

Cancer. 2017 Oct 1;123(19):3772-3780. doi: 10.1002/cncr.30804. Epub 2017 Jul 5.

46.

Interventions to Improve Oral Chemotherapy Safety and Quality: A Systematic Review.

Zerillo JA, Goldenberg BA, Kotecha RR, Tewari AK, Jacobson JO, Krzyzanowska MK.

JAMA Oncol. 2018 Jan 1;4(1):105-117. doi: 10.1001/jamaoncol.2017.0625.

PMID:
28570732
47.

Multigene expression profile testing in breast cancer: is there a role for family physicians?

O'Brien MA, Carroll JC, Manca DP, Miedema B, Groome PA, Makuwaza T, Easley J, Sopcak N, Jiang L, Decker K, McBride ML, Moineddin R, Permaul JA, Heisey R, Eisenhauer EA, Krzyzanowska MK, Pruthi S, Sawka C, Schneider N, Sussman J, Urquhart R, Versaevel C, Grunfeld E; Canadian Team to Improve Community-Based Cancer Care Along the Continuum.

Curr Oncol. 2017 Apr;24(2):95-102. doi: 10.3747/co.24.3457. Epub 2017 Apr 27.

48.

A population-based assessment of primary care visits during adjuvant chemotherapy for breast cancer.

Bastedo SJ, Krzyzanowska MK, Moineddin R, Yun L, Enright KA, Grunfeld E.

Curr Oncol. 2017 Apr;24(2):90-94. doi: 10.3747/co.24.3431. Epub 2017 Apr 27.

49.

Use of physician services during the survivorship phase: a multi-province study of women diagnosed with breast cancer.

Kendell C, Decker KM, Groome PA, McBride ML, Jiang L, Krzyzanowska MK, Porter G, Turner D, Urquhart R, Winget M, Grunfeld E; Canadian Team to Improve Community-Based Cancer Care Along the Continuum.

Curr Oncol. 2017 Apr;24(2):81-89. doi: 10.3747/co.24.3454. Epub 2017 Apr 27.

50.

Biological aspects of human migration and mobility.

Mascie-Taylor CGN, Krzyżanowska M.

Ann Hum Biol. 2017 Aug;44(5):427-440. doi: 10.1080/03014460.2017.1313448. Review.

PMID:
28359167

Supplemental Content

Loading ...
Support Center